IONS

IONS

USD

Ionis Pharmaceuticals Inc. Common Stock

$73.550-0.240 (-0.325%)

वास्तविक समय मूल्य

Healthcare
जैव प्रौद्योगिकी
संयुक्त राज्य अमेरिका

मूल्य चार्ट

Loading Chart...

मुख्य मीट्रिक्स

बाजार मीट्रिक्स
कंपनी के मौलिक सिद्धांत
ट्रेडिंग आँकड़े

बाजार मीट्रिक्स

खुलना

$73.790

उच्च

$75.000

कम

$72.360

मात्रा

0.79M

कंपनी के मौलिक सिद्धांत

बाजार पूंजीकरण

11.9B

उद्योग

जैव प्रौद्योगिकी

देश

United States

ट्रेडिंग आँकड़े

औसत मात्रा

2.47M

एक्सचेंज

NMS

मुद्रा

USD

52-सप्ताह रेंज

कम $23.95वर्तमान $73.550उच्च $76.78

संबंधित समाचार

Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $110

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals with a Buy and raises the price target from $100 to $110.

और देखें
HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $110
Analyst Upgrades

Piper Sandler Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $77

Piper Sandler analyst Allison Bratzel maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $70 to $77.

और देखें
Piper Sandler Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $77
Analyst Upgrades

TD Cowen Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $99

TD Cowen analyst Yaron Werber maintains Ionis Pharmaceuticals with a Buy and raises the price target from $59 to $99.

और देखें
TD Cowen Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $99
Analyst Upgrades

Morgan Stanley Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $94

Morgan Stanley analyst Michael Ulz maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $90 to $94.

और देखें
Morgan Stanley Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $94
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $100

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals with a Buy and raises the price target from $95 to $100.

और देखें
HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $100
Analyst Upgrades

Barclays Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $95

Barclays analyst Gena Wang maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $80 to $95.

Analyst Upgrades

RBC Capital Maintains Outperform on Ionis Pharmaceuticals, Raises Price Target to $82

RBC Capital analyst Luca Issi maintains Ionis Pharmaceuticals with a Outperform and raises the price target from $80 to $82.

अपडेट रहें

मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।